Shanghai Labway Clinical Laboratory Co., Ltd.(XSEC:301060) added to S&P Global BMI Index
Shanghai Labway Clinical Laboratory Co., Ltd
Equities
301060
CNE100004RG8
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.66 CNY | -3.69% | -2.82% | -27.31% |
05-30 | Labway Clinical Laboratory Names Chief Financial Officer | MT |
04-26 | Shanghai Labway Clinical Laboratory Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-27.31% | 554M | |
-24.66% | 7.76B | |
+69.31% | 4.33B | |
-3.33% | 2.64B | |
+3.74% | 2.63B | |
-47.63% | 2.16B | |
-16.44% | 1.75B | |
-19.40% | 1.46B | |
+14.52% | 1.17B | |
-45.53% | 1.14B |
- Stock Market
- Equities
- 301060 Stock
- News Shanghai Labway Clinical Laboratory Co., Ltd
- Shanghai Labway Clinical Laboratory Co., Ltd.(XSEC: 301060) added to S&P Global BMI Index